NJ Allergy MD, LLC of Lodi is an Allergist in Lodi, NJ. The practice provides pediatric and adult allergy, asthma, and immunology care, treating conditions such as food allergy, eczema, asthma, hay fever, and other allergic disorders. It serves patients in the Lodi community and holds a 4.40 rating based on customer reviews.
The clinic recently announced a partnership with The Medical Group of New Jersey, noting that the quality of care remains unchanged while billing procedures have been updated. The office is located at 622 Eagle Rock Avenue, Suite G3, West Orange, NJ, and operates Monday and Thursday from 9 a.m. to 5 p.m. and Wednesday from 9 a.m. to 12 p.m. Services include treatment of seasonal allergies, asthma, food allergies, skin allergies such as eczema, medication and insect allergies, sinusitis, ocular allergy, nasal polyps, hives, latex allergy, and immune disorders. Available procedures encompass biologic medication therapy, oral drug challenges, penicillin testing, allergen blood and skin testing, allergen immunotherapy, oral food challenges, pulmonary function testing, and allergen immunotherapy.
Dr. Satya Narisety, the physician leading the practice, is board‑certified in Allergy & Immunology and Pediatrics. She serves as a clinical assistant professor at Rutgers University and sits on the board of directors of the New Jersey Allergy, Asthma and Immunology Society. Dr. Narisety earned her medical degree from the University of Medicine and Dentistry of New Jersey, completed pediatric residency at New York University, and finished an Allergy & Immunology fellowship at Johns Hopkins University, where she treated severe asthma, food allergy, eczema, urticaria, angioedema, and immunodeficiency and participated in clinical trials for food allergy therapies. Her scholarly contributions include multiple peer‑reviewed publications on oral immunotherapy and food allergy management.
With board‑certified expertise in both pediatric and adult allergy care, NJ Allergy MD, LLC of Lodi delivers comprehensive, evidence‑based treatment to the Lodi community.